复方玄驹胶囊联合洛美沙星治疗慢性前列腺炎90 例分析.pdf

Z5-F90sy,a,Rnull!null(8=DUS,nullnull710005)Knull1null:Z5-Fr4bZE:a1&5vZE,|180-FsFvF90bF(0null4g,1Q/d,g；FFZ53,3Q/d,g,(41bT:S3-F(NIH-CPSI)#-FA%b4,F9rq72null2%vF9rq48null9%(P0null05)b:Z5-Frz,5wb1oMnull5；-F；AnalysisofFufangXuanjuCapsulePlusLomefloxacininthetreatmentofchronicprostatitisnullnullQULi-ming,LIHui-ning,GUOTao(DepartmentofUrology,TheSecondPeoplenullsHospitalofShaanxiProvince,XinullanShaanxi710005,China)Abstract:ObjectiveToobservetheefficacyofFufangXuanjuCapsuleplusLomefloxacininthetreatmentofChronicprostatitisnullMethodsUsingrandomandself-controlledclinicaltrail,wedivided180patienswithChronicprostatitisintotreatgroupandcontrolgroupnullEachgroup90allgivenLomefloxacinpills0null4g,onetimeperdaynullTreatgroupaddedFufangXuanjuCapsulethreepills,threetimesperdaynullCourseoftreatmentwere4weeksnullResultWeevaluatedtheconsequenceswithNIHchronicprostatitissyndromeindex(NIH-CPSI)andthewhitebloodcellnumbersofprostaticmassageliquidforeveryonenullAfter4weeks,totaleffectiverateoftreatgroupwas72null2%,higherthancontrolgroup(48null9%)(P10b-FA%#10/HP,xl8(+)bP0ZEb|sFvF90bFM-1852,(33null87null1),h611,(11null02null8)；vF1853,(35null88null3),h318,(8null14null7bFhV1b1null2null0Z:F7S0,(0null4g,1Q/d,g；FN$FZ5,(S)0,-FA%910nullHP1?；Ar:NIH-CPSI#-FA%9-V；r:NIH-CPSI#-FA%9-25%50%；r:NIH-CPSI#-FA%9-25%bArh9Arq,aArrh9rqb1null4nulld9ZE:SPSS12null0forWindowsqyoi9s,9null2_,_null=0null05,Vst_,dsSd_b2nullTFrq72null2%vF9rq48null9%(Pa*ayb%),Cf-FV?B1&f%h,V?yBtGF-F=?31&fs9bHW,S=-FZEvLl,7iZ10bNhid1%h11b,vDn3Y9V/v6b-F,-rM,F3,0VrhM,hMrr0ib-F,BpT,04-FF=12bF-F5,rTibyN,40H,14abq0bSv0+,-FT,V,i-F,Pr0i13bSv0,lqaF)aF00zaeZL(400mg,1Q/d)an+bUbk-Frq48null9%,-FrTBbV?00d%)1bZ504,/aamrbV,Z5VAl8%5Yi9,Ol9,zfTFT14bVyB5bkFrqr72null2%,vF1,sd9ilbF$FZ5V5,-FA_%,OnQ,7O43,|z5r,5wb4nullID1nullSchaefferAJ,KnaussJS,LandisJR,etalnullLeukocyteandbactenullrialcountsdonotcorrelatewithseverityofsymptomsinmenwithchronicprostatitis:theNationalInstitutesofHealthchronicprostatitiscohortstudyJnullJUrol,2002,168(3):1048null2nully,k,null-FfpJnullS3S,2002,16(4):305null3nullDplnullRxfp-FJnull3S,2004,10(2):145null4nullnullUSMnull62:S/,2004:584-586null5nullCHEAHPY,LIONGML,YUENKH,etalnullReliabilityandvanulllidityofthenationalInstitutesofhealth:chronicprostatitissymptomindexinamalaysianpopulationJnullWorldJUrol,2006,24(1):79null6nullLiangCZ,ZhangXJ,HaoY,etalnullAnepidemiologicalstudyofpanulltientswithchronicprostatitisJnullBrJUrolInt,2004,94(1):568null7null,null_,null-F?hysJnullB+Dv,2002,22(9):846.8null(null,3,M,null?p-FTJnullUS,2002,23(6):328null9nullSJ,null,fnull,nulld%)-Ffhy)JnullUS,2000,21(7):446null10nullELISTJnullEffectsofpollenextractpreparationprostatnullpoltitonlowerurinarytractsymptomsinpatientswithchronicnonbacterialprostatitisnullchronicpelvicpainsyndrome:arandomized,double-blind,placebo-controlledstudyJnullUrology,2006,67(1):60null11nullPatientinformation:ManagingprostatitisJnullClevClinMed,2001,68(5):398null12nullFowlerJEJrnullAntimicrobialtherapyforbacterialandnonbactenullrialprostatitisJnullUrology,2007,60(6):24null13nullk,+.,.-F$ZJ.5US2001,16(1):471null14nullInull,null,Z5fTFTJnull0,2003,34(2):154bl:2010-12-17nullIn:SmF354%null(+8*gD,+null*null614200)Knull1null:)SmPF3bZE:4s2009M2010MSmPF3fb2009MF3,0HW(5null25db2010MBF3,(0HW3null11dbT:0ZmqAsb:SmPF34B4aNa0sz0,OPb1oMnullSm；F3；4ObstetricsurgeryintheclinicalobservationofprophylacticantibioticsnullnullPENGLi-tao(SichuanEmeishanCityPeoplenullsHospital,EmeishanSichuan614200,China)Abstract:ObjectiveToinvestigatehowthesurgeryobstetricantibioticprophylaxisnullMethodsinourhospitalin2009,2010,theannualoutputofsurgicalprophylacticantibioticsnull2009usetwoormoreantibiotics,medicationaverageof5null25daysnullAnantibioticusein2010,theaveragetreatnullmenttimeof3null11daysnullResultsBothregimensinpatientsaftersurgerynosignificantdifferenceininfectionratesnullConclusion